E Vallée

872 citations

31 papers · 642 indexed · h-index 16

Impact in

Molecular Medicine top 2%
- Antibiotic Resistance in Bacteria
Pharmacology top 5%
- Antibiotics Pharmacokinetics and Efficacy

Papers in ⓘ

Molecular Medicine 10
- Antibiotic Resistance in Bacteria 10
Applied Microbiology and Biotechnology 2

Co-authors: E. Azoulay-Dupuis (14 shared papers)J J Pocidalo (7 shared papers)E Bergogne-Bérézin (8 shared papers)Pierre Moine (5 shared papers)J J Pocidalo (4 shared papers)J Bauchet (4 shared papers)A. Philippon (2 shared papers)Jean Pierre Bedos (4 shared papers)
Journals: Antimicrobial Agents and Chemotherapy (9 papers)Journal of Antimicrobial Chemotherapy (5 papers)Journal of Pharmacology and Experimental Therapeutics (1 paper)The Journal of Infectious Diseases (1 paper)Journal of Clinical Microbiology (1 paper)
Partner nations: France United States Tunisia

In The Last Decade

E Vallée

28 papers receiving 614 citations

Peers

Countries citing papers authored by E Vallée

Since Specialization

Citations

This map shows the geographic impact of E Vallée's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by E Vallée with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites E Vallée more than expected).

Fields of papers citing papers by E Vallée

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by E Vallée. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by E Vallée. The network helps show where E Vallée may publish in the future.

Co-authors

The 25 scholars most cited alongside E Vallée, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with E Vallée Line = papers co-authored together E Vallée links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Showing the 20 most-cited of 31 papers — load more, or switch the sort, to bring in the rest.

#	Work
1	Diagnosis of tuberculosis by Amplicor Mycobacterium tuberculosis test: a multicenter study Journal of Clinical Microbiology ·E Carpentier, B Drouillard, M. Dailloux, D Moinard, E Vallée, Bas E. Dutilh, J. Maugein, E Bergogne-Bérézin, B Carbonnelle	1995	79
2	Antipneumococcal Activity of Ciprofloxacin, Ofloxacin, and Temafloxacin in an Experimental Mouse Pneumonia Model at Various Stages of the Disease The Journal of Infectious Diseases ·E. Azoulay-Dupuis, J.P. Bédos, E Vallée, Dwight J. Hardy, R. N. Swanson, J J Pocidalo	1991	50
3	Relationship between Capsular Type, Penicillin Susceptibility, and Virulence of Human Streptococcus pneumoniae Isolates in Mice Antimicrobial Agents and Chemotherapy ·E. Azoulay-Dupuis, Véronique Rieux, Martine Muffat‐Joly, Jean Pierre Bedos, E Vallée, Catherine Rivier, Raúl Istúriz, C Carbon, Pierre Moine	2000	50
4	In vivo efficacy of a broad-spectrum cephalosporin, ceftriaxone, against penicillin-susceptible and -resistant strains of Streptococcus pneumoniae in a mouse pneumonia model Antimicrobial Agents and Chemotherapy ·Pierre Moine, E Vallée, E. Azoulay-Dupuis, Philippe Bourget, J.P. Bédos, J Bauchet, J J Pocidalo	1994	49
5	Distribution of β-lactamases and phenotype analysis in clinical strains of Acinetobacter calcoaceticus Journal of Antimicrobial Chemotherapy ·M. L. Joly-Guillo, E Vallée, E Bergogne-Bérézin, A. Philippon	1988	48
6	Activity of sulbactam in combination with ceftriaxone in vitro and in experimental endocarditis caused by Escherichia coli producing SHV-2-like beta-lactamase Antimicrobial Agents and Chemotherapy ·B. Fantin, B. Pangon, G. Potel, François Caron, E Vallée, J M Vallois, J. Mohler, A Buré, A. Philippon, C Carbon	1990	47
7	In vivo efficacy of a new fluoroquinolone, sparfloxacin, against penicillin-susceptible and -resistant and multiresistant strains of Streptococcus pneumoniae in a mouse model of pneumonia Antimicrobial Agents and Chemotherapy ·E. Azoulay-Dupuis, E Vallée, Benoît Veber, J.P. Bédos, J Bauchet, J J Pocidalo	1992	45
8	Prophylactic and therapeutic activities of azithromycin in a mouse model of pneumococcal pneumonia Antimicrobial Agents and Chemotherapy ·E. Azoulay-Dupuis, E Vallée, J.P. Bédos, Martine Muffat‐Joly, J J Pocidalo	1991	39
9	Synergy between amoxicillin and gentamicin in combination against a highly penicillin-resistant and -tolerant strain of Streptococcus pneumoniae in a mouse pneumonia model Antimicrobial Agents and Chemotherapy ·C Darras-Joly, Jean Pierre Bedos, C Sauve, Pierre Moine, E Vallée, C Carbon, E. Azoulay-Dupuis	1996	35
10	Activity and local delivery of azithromycin in a mouse model of Haemophilus influenzae lung infection Antimicrobial Agents and Chemotherapy ·E Vallée, E. Azoulay-Dupuis, J J Pocidalo, E Bergogne-Bérézin	1992	27
11	Correlation between macrolide lung pharmacokinetics and therapeutic efficacy in a mouse model of pneumococcal pneumonia Journal of Antimicrobial Chemotherapy ·Benoît Veber, E Vallée, J.M. Desmonts, J J Pocidalo, E. Azoulay-Dupuis	1993	24
12	Amoxicillin dose-effect relationship with Streptococcus pneumoniae in a mouse pneumonia model and roles of in vitro penicillin susceptibilities, autolysis, and tolerance properties of the strains Antimicrobial Agents and Chemotherapy ·E. Azoulay-Dupuis, Pierre Moine, Jean Pierre Bedos, Véronique Rieux, E Vallée	1996	24
13	Comparative activity of fluorinated quinolones in acute and subacute Streptococcus pneumoniae pneumonia models: efficacy of temafloxacin Journal of Antimicrobial Chemotherapy ·E. Azoulay-Dupuis, J. P. Bédos, E Vallée, J J Pocidalo	1991	21
14	Efficacy and ocular penetration of sparfloxacin in experimental streptococcal endophthalmitis Antimicrobial Agents and Chemotherapy ·I Cochereau-Massin, J Bauchet, S. Marrakchi-Benjaafar, Azzam Saleh‐Mghir, F. Faurisson, J M Vallois, E Vallée, J J Pocidalo	1993	21
15	Individual and combined activities of clarithromycin and its 14-hydroxy metabolite in a murine model of Haemophilus influenzae infection Journal of Antimicrobial Chemotherapy ·E Vallée, E. Azoulay-Dupuis, R. N. Swanson, E Bergogne-Bérézin, J J Pocidalo	1991	19
16	Pharmacokinetics of four fluoroquinolones in an animal model of infected lung Journal of Antimicrobial Chemotherapy ·E Vallée, Etienne Dupuis, J J Pocidalo, E Bergogne-Bérézin	1991	16
17	Pneumonies à S. pneumoniae de sensibilité diminuée à la pénicilline : données épidémiologiques, facteurs de risque et impact thérapeutique Médecine et Maladies Infectieuses ·J.P. Bédos, E Vallée, Pierre Moine, P. Geslin, Cl. Chastang	1995	10
18	[Vancomycin in meningitis caused by penicillin G resistant Streptococcus pneumoniae]. PubMed ·P. Longuet, E Vallée, M Michel, Christian Perronne, Michelin Janvier, C. Leport, Vildé Jl	1993	8
19	[Comparative activity of imipenem, ceftazidime and cefotaxime against Acinetobacter calcoaceticus]. PubMed ·E Vallée, Marie‐Laure Joly‐Guillou, E Bergogne-Bérézin	1990	7
20	Kinetic disposition of temafloxacin and ciprofloxacin in a murine model of pneumococcal pneumonia. Relevance for drug efficacy. Journal of Pharmacology and Experimental Therapeutics ·E Vallée, E. Azoulay-Dupuis, J Bauchet, J J Pocidalo	1992	6

About E Vallée

E Vallée is a scholar working on Molecular Medicine, Applied Microbiology and Biotechnology, Pharmacology, Microbiology and Epidemiology, having authored 31 papers that have together received 642 indexed citations. Recurring topics across this work include Pneumonia and Respiratory Infections (17 papers), Antibiotics Pharmacokinetics and Efficacy (16 papers), Antibiotic Resistance in Bacteria (10 papers), Tuberculosis Research and Epidemiology (4 papers), Bacterial Infections and Vaccines (4 papers), Cancer therapeutics and mechanisms (3 papers), Pneumocystis jirovecii pneumonia detection and treatment (3 papers) and Streptococcal Infections and Treatments (3 papers). The work is most often cited by research in Molecular Medicine (266 citations), Pharmacology (307 citations), Applied Microbiology and Biotechnology (30 citations), Microbiology (80 citations) and Epidemiology (419 citations). E Vallée has collaborated with scholars based in France, United States and Tunisia. Frequent co-authors include E. Azoulay-Dupuis, J J Pocidalo, E Bergogne-Bérézin, Pierre Moine, J J Pocidalo, J Bauchet, A. Philippon, Jean Pierre Bedos, C Carbon and Martine Muffat‐Joly. Their work appears in journals such as Antimicrobial Agents and Chemotherapy, Journal of Antimicrobial Chemotherapy, Journal of Pharmacology and Experimental Therapeutics, The Journal of Infectious Diseases and Journal of Clinical Microbiology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact